Cargando…

Economic evaluation of margetuximab vs. trastuzumab for pretreated ERBB2-positive advanced breast cancer in the US and China

OBJECTIVE: To assess the economic evaluation of margetuximab plus chemotherapy over trastuzumab plus chemotherapy for women with pretreated ERBB2-positive advanced breast cancer in the United States (US) and China. METHODS: Based on the SOPHIA trial, a three-state Markov model was developed to compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Zhiyuan, Xu, Xin, Gao, Jie, Chen, Ling, Zhu, Qiuyan, Wang, Jinli, Yan, Xiaoyu, Chen, Bohua, Zhu, Yumei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500445/ https://www.ncbi.nlm.nih.gov/pubmed/36159262 http://dx.doi.org/10.3389/fpubh.2022.942767

Ejemplares similares

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
por: Rugo, Hope S., et al.
Publicado: (2021)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
por: Xiang, Guiyuan, et al.
Publicado: (2021)

Synergistic antitumor effect of the anti-ErbB2 antibodies trastuzumab and H2-18 on trastuzumab-resistant gastric cancer cells
por: Wang, Chao, et al.
Publicado: (2021)

Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis
por: Feng, Mingyang, et al.
Publicado: (2022)

Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC
por: Chen, Pingyu, et al.
Publicado: (2022)

Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody
por: Wang, Chao, et al.
Publicado: (2017)

An anti-ErbB2 fully human antibody circumvents trastuzumab resistance
por: Lu, Qiong, et al.
Publicado: (2016)

Margetuximab: An active alternative for later‐line therapy in patients with HER2‐positive advanced breast cancer
por: Zhou, Yunxiang, et al.
Publicado: (2023)

Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab
por: Zhang, Liyi
Publicado: (2021)

Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
por: Schlam, Ilana, et al.
Publicado: (2022)

A Review of Margetuximab-Based Therapies in Patients with HER2-Positive Metastatic Breast Cancer
por: Alasmari, Moudi M.
Publicado: (2022)

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
por: Rugo, Hope S., et al.
Publicado: (2023)

Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model
por: Hermes, M, et al.
Publicado: (2008)

Commentary: Examining contextual factors contributing to differentials in COVID-19 mortality in U.S. vs. India
por: Zanwar, Preeti Pushpalata, et al.
Publicado: (2022)

Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US
por: Wang, Yingcheng, et al.
Publicado: (2021)

Educational disparities in adult health across U.S. states: Larger disparities reflect economic factors
por: Montez, Jennifer Karas, et al.
Publicado: (2022)

Sugemalimab plus chemotherapy vs. chemotherapy for metastatic non-small-cell lung cancer: A cost-effectiveness analysis
por: Liang, Xueyan, et al.
Publicado: (2023)

The economic burden of malaria inpatients and its determinants during China's elimination stage
por: Chen, Fangfei, et al.
Publicado: (2022)

Ea$ing into the USA: study protocol for adapting the Economic and Social Empowerment (EA$E) intervention for US-based, forcibly based populations
por: Gupta, Jhumka, et al.
Publicado: (2023)

Recent Spatiotemporal Patterns of US Lung Cancer by Histologic Type
por: Lewis, Denise Riedel, et al.
Publicado: (2017)

Metagenomic Next-Generation Sequencing vs. Traditional Microbiological Tests for Diagnosing Varicella-Zoster Virus Central Nervous System Infection
por: Zhu, Yunqi, et al.
Publicado: (2022)

Complete response in patient with liver metastasis of HER2-positive breast cancer following therapy with margetuximab: a case report
por: Chang, Haiyan, et al.
Publicado: (2023)

Novel paradigm of mosquito-borne disease control based on self-powered strategy
por: Wang, Junhao, et al.
Publicado: (2023)

Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04
por: Zhan, Mei, et al.
Publicado: (2023)

Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam
por: Nguyen-Thi, Hai-Yen, et al.
Publicado: (2020)

Economic Burden of Myocardial Infarction Combined With Dyslipidemia
por: Chen, Pingyu, et al.
Publicado: (2021)

Environmental exposure to organophosphate esters and suspected non-alcoholic fatty liver disease among US adults: A mixture analysis
por: Chai, Haisheng, et al.
Publicado: (2022)

Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis
por: Liu, Xiaoyan, et al.
Publicado: (2021)

An Empirical Study of Economic Cycle, Air Quality, and National Health Since Reform and Opening Up
por: Chai, Kuang-Cheng, et al.
Publicado: (2021)

Distribution of health problems at the general outpatients' clinic of the University of Hong Kong-Shenzhen Hospital: A cross-sectional study
por: Chen, Kai, et al.
Publicado: (2022)

Social position and economic system justification in Canada: Implications for advancing health equity and social justice from an exploratory study of factors shaping economic system justification
por: Card, Kiffer G., et al.
Publicado: (2022)

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
por: Singer, Josef, et al.
Publicado: (2012)

Relationship between health literacy and COVID-19 knowledge: A cross-sectional study
por: Tao, Zhenbo, et al.
Publicado: (2023)

The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer
por: Wang, Lingfei, et al.
Publicado: (2017)

Stochastic Dynamics of the COVID-19 Case-Fatality Ratios in Indonesia, Malaysia, and the Philippines: Economic Implications for the Post-COVID-19 Era
por: Shi, Zili, et al.
Publicado: (2021)

Mobilising cross-sector collaborations to improve population health in US rural communities: a qualitative study
por: Zhu, Xi, et al.
Publicado: (2019)

Risk Factors Identification of Unsafe Acts in Deep Coal Mine Workers Based on Grounded Theory and HFACS
por: Yang, Li, et al.
Publicado: (2022)

Influencing Factors, Formation Mechanism, and Pre-control Methods of Coal Miners′ Unsafe Behavior: A Systematic Literature Review
por: Yang, Li, et al.
Publicado: (2022)

A guideline for economic evaluations of vaccines and immunization programs in China
por: Fang, Hai, et al.
Publicado: (2022)

Nutrition Literacy of Middle School Students and Its Influencing Factors: A Cross-Sectional Study in Chongqing, China
por: Zeng, Mao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pm2m747e358o6iuhmjch9pahql